SUMMER MITCHELL: Open Payments
NPI 1538558473 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 17 payments from 7 companies in 2025. Trend: 2023 $633 · 2024 $419 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| PFIZER INC. | 1 | $41 |
| Kestra Medical Technology Services, Inc. | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| ABIOMED | 1 | $27 |
Products named: LEQVIO, VERQUVO, VYNDAQEL, Assure WCD, AMVUTTRA, Kerendia, ENTRESTO.
Industry payments across MS — which companies pay providers there.
